LINC00461 was shown to inhibit apoptosis and promoting recurrence in DLBCL through miR-411-5p/BNIP3 pathway23.Through meta-analysis, Xu et al. found that lncRNA expression profile could aid in the diagnosis and classification of DLBCL, and abnormal lncRNA expression level was associated with poor prognosis of DLBCL patients, indicating that lncRNAs can be used as candidate prognostic biomarkers for DLBCL24. Here, BNIP3 is linked to diffuse large B-cell lymphoma.